EMBO Molecular Medicine (Apr 2024)

Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism

  • Jun Wu,
  • Or Kakhlon,
  • Miguel Weil,
  • Alexander Lossos,
  • Berge A Minassian

DOI
https://doi.org/10.1038/s44321-024-00063-9
Journal volume & issue
Vol. 16, no. 5
pp. 1047 – 1050

Abstract

Read online

In this Correspondence, B. Minassian and colleagues report that GHF201, an autophagy activator shown to diminish abnormal glycogen aggregates in a mouse model of Adult Polyglucosan Body Disease, fails to reduce such accumulations in a mouse model of Lafora disease.